Pro-life group calls for Trump admin to fire FDA head Marty Makary over delayed abortion drug report
The move comes after the FDA quietly approved a new generic version of the abortion drug mifepristone in October.
The conservative nonprofit group Susan B. Anthony Pro-Life America called Tuesday for the Trump administration to fire Food and Drug Administration Commissioner Marty Makary over reports he delayed a review of safety data for an abortion drug.
Sources told Bloomberg News on Monday that Makary has quietly told the agency to delay the review, even though the commissioner and Health and Human Services Secretary Robert F. Kennedy Jr. have told lawmakers and state attorneys general for months that they are actively conducting a review of the abortion drug mifepristone.
HHS has denied the allegations of slow-walking the report, stating that reviews take time to ensure the science is right.
“Enough is enough: FDA Commissioner Makary should be fired immediately," SBA President Marjorie Dannenfelser said. "The FDA is doing nothing while every single day abortion drugs take the lives of children, put women and girls at serious risk, empower abusers and trample state pro-life laws.
"The FDA needs a new commissioner who will immediately reinstate in-person dispensing as it existed under President Trump’s first term and immediately conduct a comprehensive study," she continued. "Commissioner Makary is severely undermining President Trump and Vice President Vance’s pro-life credentials and their position that states should have the right to enact and enforce pro-life protections. Makary must go."
The move comes after the FDA quietly approved a new generic version of mifepristone in October.
Misty Severi is a news reporter for Just The News. You can follow her on X for more coverage.